Bristol Myers Squibb
Information
BMS is one of the largest biopharmaceutical companies in the world. The new cell therapy facility at the Leiden Bio Science Park (LBSP) will be its fifth such facility in the world and its first European one. Its aim is to bring cell therapy closer to European patients. The facility will have the latest technology and production equipment for cell therapy development, thus enabling the company to increase its capacity for treating cancer patients.
BMS is one of the largest biopharmaceutical companies in the world. The new cell therapy facility at the Leiden Bio Science Park (LBSP) will be its fifth such facility in the world and its first European one. Its aim is to bring cell therapy closer to European patients. The facility will have the latest technology and production equipment for cell therapy development, thus enabling the company to increase its capacity for treating cancer patients.
Location
-
2021-2024
Run time
-
Life, Science & Health
Type
-
Gemeente Leiden Universiteit Leiden
Landowner
-
19.000 m2
Surface area
- Credits Architect: KuiperCompagnons
- Roadworks Roadworks may affect traffic in the local area. For more information, please press the red button ‘All roadworks’.
Comparable projects
-
Planned Bristol Myers SquibbAmerican pharmaceutical company Bristol Myers Squibb (BMS) will be building a new cell the... -
Planned Sports and Examination CentreGood sports facilities are indispensable on a university campus. The new Sports and Examin... -
Completed HALIXThe growing biopharmaceutical company HALIX has acquired a new medical production testing ...